Sandbox
Data integrity is a fundamental pillar of pharmaceutical quality assurance. Regulators rely on complete, accurate, and secure records to verify that drugs are safe for commercial release. In recent years, data integrity has become a primary target of FDA and EMA regulatory inspections. This article explores the core standards of data management.
The ALCOA Framework
The core of data integrity is summarized by the **ALCOA** acronym, representing five critical attributes of records:
- Attributable: Every record must clearly show who created it, when, and on which instrument.
- Legible: Data must be easy to read and understand throughout the entire product lifecycle.
- Contemporaneous: Activity must be recorded at the exact time it occurs, not post-dated.
- Original: The first recording of data (raw data) must be preserved, not overwritten.
- Accurate: Data must be free from errors, edits, or omissions, reflecting the true results.
The "+" Elements: Complete, Consistent, Enduring, and Available
The framework has been expanded to **ALCOA+**, incorporating four additional principles:
- Complete: All tests, including failed runs, must be recorded and archived.
- Consistent: Data must follow an expected chronological sequence.
- Enduring: Records must be saved on durable media (e.g., secure databases, not scrap paper).
- Available: Data must be accessible for review and regulatory audits at any time.
Audit Trails and User Permissions
Electronic laboratory systems must utilize active **Audit Trails** that log every configuration change, data entry, or deletion automatically. Access levels should be controlled, preventing lab analysts from modifying or deleting files, ensuring total accountability.
